• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征是否会增加肾功能正常患者的对比剂肾病发生率?

Does metabolic syndrome increase contrast-induced nephropathy in patients with normal renal function?

作者信息

Shemirani Hasan, Hosseini Ali

机构信息

Cardiology Department, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute and Chamran Cardiovascular and Medical Research Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Chamran Cardiovascular and Medical Research Hospital and Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Res Med Sci. 2024 Jan 30;29:5. doi: 10.4103/jrms.jrms_136_21. eCollection 2024.

DOI:10.4103/jrms.jrms_136_21
PMID:38524741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10956558/
Abstract

BACKGROUND

Contrast-induced nephropathy (CIN) is associated with increased mortality and morbidity in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention. This study aimed to compare the incidence of CIN in two groups of patients with and without metabolic syndrome (Mets) with baseline normal renal function.

MATERIALS AND METHODS

In this case - control study, 260 patient candidates for CAG, 130 patients with Mets and 130 patients without Mets participated, and their serum creatinine (Cr) level before and the 48 and 72 h after the angiography was measured. The incidence of CIN was compared in two groups. Two-way analysis of variance with repeated measures and univariate and multivariate logistic regression models.

RESULTS

The results showed a higher chance of being Mets with raising in triglyceride (adjusted odds ratio = 1.05, 95% confidence interval = (1.03-1.06), < 0.001), Fasting blood glucose (1.010 [1.001-1.019], = 0.025), and diastolic blood pressure (1.07 [1.07-1.20], < 0.001), but declining in high-density lipoprotein-cholesterol (HDL-C) (0.91 [0.85-0.98], = 0.008). Furthermore, blood urea nitrogen (BUN) and Cr level was raised in 48 and 72 h after contrast injection in both groups (All < 0.001). Furthermore, in 48 h (3.11 [1.12-9.93], = 0.016) and 72 h (2.82 [1.07-8.28], = 0.021) after injection, a total of 25 patients had an increased Cr level and a significant difference between Mets and without Mets groups. The developing Mets had a significant association with the increased risk of AKI, which increased the chance of developing nephropathy (7.14 [2.27-22.5], = 0.001).

CONCLUSION

Mets, together with other risk factors, increased the overall risk of CIN development. Therefore, the incidence of CIN in patients Mets is significantly higher than that of patients without Mets, indicating a more important CIN risk factor.

摘要

背景

造影剂肾病(CIN)与接受冠状动脉造影(CAG)和经皮冠状动脉介入治疗的患者死亡率和发病率增加相关。本研究旨在比较两组基线肾功能正常、患有和未患有代谢综合征(Mets)的患者中CIN的发生率。

材料与方法

在这项病例对照研究中,260例CAG候选患者参与其中,其中130例患有Mets,130例未患有Mets,测量他们造影前、造影后48小时和72小时的血清肌酐(Cr)水平。比较两组中CIN的发生率。采用重复测量的双向方差分析以及单因素和多因素逻辑回归模型。

结果

结果显示,随着甘油三酯升高(调整后的优势比 = 1.05,95%置信区间 =(1.03 - 1.06),P < 0.001)、空腹血糖(1.010 [1.001 - 1.019],P = 0.025)和舒张压(1.07 [1.07 - 1.20],P < 0.001)升高,患Mets的可能性增加,但高密度脂蛋白胆固醇(HDL - C)降低(0.91 [0.85 - 0.98],P = 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5421/10956558/294cac2538e2/JRMS-29-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5421/10956558/294cac2538e2/JRMS-29-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5421/10956558/294cac2538e2/JRMS-29-5-g001.jpg

相似文献

1
Does metabolic syndrome increase contrast-induced nephropathy in patients with normal renal function?代谢综合征是否会增加肾功能正常患者的对比剂肾病发生率?
J Res Med Sci. 2024 Jan 30;29:5. doi: 10.4103/jrms.jrms_136_21. eCollection 2024.
2
[Prevention and Treatment of Shenkang Injection for Contrast-induced Nephropathy in Elder Patients with Chronic Kidney Disease].参康注射液防治老年慢性肾脏病患者造影剂肾病的研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Jul;36(7):792-796.
3
Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.非糖尿病患者择期经皮冠状动脉介入治疗后代谢综合征对造影剂肾病发生的影响。
Clin Cardiol. 2015 Mar;38(3):150-6. doi: 10.1002/clc.22364.
4
Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.血清渗透压作为择期冠状动脉造影后对比剂肾病的潜在预测因子。
Int Urol Nephrol. 2020 Mar;52(3):541-547. doi: 10.1007/s11255-020-02391-4. Epub 2020 Feb 1.
5
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.糖尿病前期与接受冠状动脉造影或经皮介入治疗患者发生对比剂肾病的风险
Diabetes Res Clin Pract. 2014 Dec;106(3):458-64. doi: 10.1016/j.diabres.2014.09.041. Epub 2014 Oct 6.
6
Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention.糖化血红蛋白水平与接受冠状动脉造影/经皮冠状动脉介入治疗的糖尿病患者对比剂肾病风险的关系。
BMC Nephrol. 2021 Jun 2;22(1):206. doi: 10.1186/s12882-021-02405-y.
7
Association of the blood urea nitrogen-to-left ventricular ejection fraction ratio with contrast-induced nephropathy in patients with acute coronary syndrome who underwent percutaneous coronary intervention.血尿素氮与左心室射血分数比值与行经皮冠状动脉介入治疗的急性冠状动脉综合征患者对比剂肾病的关系。
Int Urol Nephrol. 2019 Mar;51(3):475-481. doi: 10.1007/s11255-018-2052-1. Epub 2019 Jan 2.
8
Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.对比剂诱导的经皮冠状动脉介入治疗急性冠脉综合征患者的肾病:STEMI 与 NSTEMI 的差异。
Clin Res Cardiol. 2009 Dec;98(12):765-72. doi: 10.1007/s00392-009-0058-5. Epub 2009 Oct 23.
9
Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.乙酰半胱氨酸预防冠状动脉造影术后对比剂肾病
Am Heart J. 2003 Dec;146(6):E23. doi: 10.1016/S0002-8703(03)00511-8.
10
Lower blood vitamin D levels are associated with an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography.血液中维生素 D 水平较低与接受冠状动脉造影的患者对比剂诱导肾病的发生率增加有关。
Can J Cardiol. 2014 Apr;30(4):428-33. doi: 10.1016/j.cjca.2013.12.029. Epub 2014 Jan 4.

本文引用的文献

1
The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?静脉造影对比剂肾病争议:风险有多大?
Am J Kidney Dis. 2020 Jan;75(1):105-113. doi: 10.1053/j.ajkd.2019.05.022. Epub 2019 Aug 28.
2
Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.对比剂后急性肾损伤-第 1 部分:定义、临床特征、发生率、对比剂的作用及危险因素:对 ESUR 对比剂安全委员会指南更新的建议。
Eur Radiol. 2018 Jul;28(7):2845-2855. doi: 10.1007/s00330-017-5246-5. Epub 2018 Feb 9.
3
Contrast-induced nephropathy following angiography and cardiac interventions.
血管造影和心脏介入术后的对比剂肾病
Heart. 2016 Apr;102(8):638-48. doi: 10.1136/heartjnl-2014-306962. Epub 2016 Feb 8.
4
Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.非糖尿病患者择期经皮冠状动脉介入治疗后代谢综合征对造影剂肾病发生的影响。
Clin Cardiol. 2015 Mar;38(3):150-6. doi: 10.1002/clc.22364.
5
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.糖尿病前期与接受冠状动脉造影或经皮介入治疗患者发生对比剂肾病的风险
Diabetes Res Clin Pract. 2014 Dec;106(3):458-64. doi: 10.1016/j.diabres.2014.09.041. Epub 2014 Oct 6.
6
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后:来自国家心血管数据注册库(NCDR)导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.
7
Dyslipidemia in patients with chronic and end-stage kidney disease.慢性肾脏病和终末期肾病患者的血脂异常
Cardiorenal Med. 2013 Oct;3(3):165-177. doi: 10.1159/000351985. Epub 2013 Jul 13.
8
Metabolic syndrome and associated chronic kidney diseases: nutritional interventions.代谢综合征及相关慢性肾脏病:营养干预。
Rev Endocr Metab Disord. 2013 Sep;14(3):273-86. doi: 10.1007/s11154-013-9268-2.
9
Chronic kidney disease: global dimension and perspectives.慢性肾脏病:全球维度与展望。
Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.
10
Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?静脉注射造影剂真的比动脉内注射的肾毒性更小吗?
Eur Radiol. 2012 Jun;22(6):1366-71. doi: 10.1007/s00330-011-2371-4. Epub 2012 Feb 4.